Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Volcano Corp. buys Crux Biomedical

Executive Summary

The same month it netted $445.3mm through a notes offering, Volcano Corp. has agreed to buy closely held minimally invasive cardiovascular device company Crux Biomedical Inc. for $36mm in cash, up to $3.1mm in transaction expenses, and earn-outs, including $3mm if the company gets 510(k) approval by June 30, 2013 for a retrieval device in development. Crux shareholders may receive additional cash payments based on sales (for up to four years post-commercialization).

Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Includes Earnout
    • Payment Includes Cash for Equity

Related Companies